Yes, and I see that this may well be the first product to commercialisation, which can then fund for the big investment into the 12CQ longer term. As I understand it, the biochip will be easier and simpler to commercialise than the 12CQ, because it will be fairly independent of other business partners, manufacturing, and integration into a product. Whereas the biochip itself is a product, without need to integrate into someone elses product as a component.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $58.61M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 24.0¢ | 22.5¢ | $64.20K | 278.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 138152 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 61500 | 2 |
View Market Depth
| Last trade - 12.37pm 27/06/2025 (20 minute delay) ? |
| AXE (ASX) Chart |